Brief: Bioxytran Seeking Partners For Late Stage Treatment Of Wuhan Coronavirus Using Bxt-25
05/02/2020 14:14
Feb 5 (Reuters) - Bioxytran Inc BIXT.PK :
* BIOXYTRAN SEEKING PARTNERS FOR LATE STAGE TREATMENT OF
WUHAN
CORONAVIRUS USING BXT-25
Source text for Eikon: ID:nGNX3P9grj
Further company coverage: BIXT.PK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Bioxytran
See all newsUS officials pressed China on rare earths, farm goods commitments, Bessent says (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran